Issue 22, 2021

A cerium oxide@metal–organic framework nanoenzyme as a tandem catalyst for enhanced photodynamic therapy

Abstract

An O2 self-evolving core–shell theranostic nanohybrid was developed by encapsulating a nanoenzyme cerium oxide (CeOx) in a metal–organic framework (MOF). The hybrid reveals a 9-fold higher apoptotic percentage than bare CeOx in a harsh hypoxic microenvironment through tandem homogenous catalysis. Simultaneously, the oxygen-promoted therapeutic efficiency was self-monitored by the hybrid with caspase-3 activation, paving the way for MOF-functionalized nanoenzymes in theranostics.

Graphical abstract: A cerium oxide@metal–organic framework nanoenzyme as a tandem catalyst for enhanced photodynamic therapy

Supplementary files

Article information

Article type
Communication
Submitted
01 Jan 2021
Accepted
29 Jan 2021
First published
30 Jan 2021

Chem. Commun., 2021,57, 2820-2823

A cerium oxide@metal–organic framework nanoenzyme as a tandem catalyst for enhanced photodynamic therapy

J. Liu, L. Y. Ye, W. H. Xiong, T. Liu, H. Yang and J. Lei, Chem. Commun., 2021, 57, 2820 DOI: 10.1039/D1CC00001B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements